ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 284,89
-0,97%
DAX
18 691,32
0,05%
Brent Oil
81,02
-0,63%
Bitcoin
68 016,98
-1,57%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Labcorp Holdings Inc (LH)

  7. Labcorp Holdings Inc (LH) Actualités

LH Labcorp Holdings Inc

199,46
-1,73 (-0,86%)
Dernière mise à jour : 19:14:32
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Labcorp Holdings Inc LH NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-1,73 -0,86% 199,46 19:14:32
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
200,50 197,89 201,16 201,19
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
17/5/202422:57EDGAR2Form S-8 - Securities to be offered to employees in employee..
17/5/202422:45EDGAR2Form S-3ASR - Automatic shelf registration statement of..
17/5/202422:41EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
17/5/202422:32EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/5/202422:31EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/5/202422:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
17/5/202422:10EDGAR2Form 8-K12B - Notification that a class of securities of..
16/5/202422:19EDGAR2Form 8-K - Current report
16/5/202414:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/5/202414:00PRNUSLabcorp Introduces First Trimester Screening Test to Assess..
14/5/202418:40EDGAR2Form 144 - Report of proposed sale of securities
08/5/202414:08EDGAR2Form 8-K - Current report
08/5/202412:59PRNUSLabcorp to Webcast Its Annual Meeting of Shareholders
07/5/202422:05PRNUSInvitae Receives Court Approval for Sale to Labcorp
06/5/202422:40EDGAR2Form PX14A6G - Notice of exempt solicitation submitted by..
29/4/202413:00PRNUSLabcorp Receives FDA Approval for First Companion Diagnostic..
25/4/202412:58PRNUSLabcorp Announces 2024 First Quarter Results
25/4/202403:27PRNUSLabcorp Announces Winning Bid for Select Assets of Invitae
25/4/202403:19PRNUSInvitae Enters into Agreement with Labcorp for Sale of..
15/4/202413:00PRNUSLabcorp Announces First-of-Its-Kind Test for Early..
11/4/202412:59PRNUSLabcorp Declares Quarterly Dividend
10/4/202412:49PRNUSLabcorp Receives FDA Emergency Use Authorization for Mpox..
08/4/202413:00PRNUSLabcorp Announces Expansion of Precision Oncology Portfolio..
05/4/202413:00PRNUSLabcorp Launches Labcorp® Plasma Detect™ Extending..
02/4/202413:00PRNUSLabcorp to Present Diverse Portfolio of Precision Oncology..
01/4/202414:00BWXcell Biosciences Strengthens Cell and Gene Therapy..
29/3/202414:00PRNUSThe Prelude Network® Names Labcorp Its Preferred Genetic..
28/3/202413:00PRNUSLabcorp Announces Acquisition of Select Assets of..
27/3/202412:00PRNUSLabcorp to Announce First Quarter Financial Results on April..
20/3/202412:00PRNUSLabcorp Launches pTau217 Blood Biomarker Test to Accelerate..
16/3/202415:29PRNUSLabcorp Presents New Research Demonstrating Clinical Impact..
11/3/202413:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202413:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202419:16EDGAR2Form 144 - Report of proposed sale of securities
07/3/202416:34EDGAR2Form 144 - Report of proposed sale of securities
07/3/202413:00PRNUSLabcorp Launches Weight Loss Management Testing Solutions
22/2/202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202422:35EDGAR2Form 144 - Report of proposed sale of securities
21/2/202420:38EDGAR2Form 144 - Report of proposed sale of securities
21/2/202414:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
15/2/202414:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202413:01EDGAR2Form 8-K - Current report
15/2/202412:56PRNUSLabcorp Announces 2023 Fourth Quarter and Full Year Results
13/2/202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NYSE
LH
Labcorp
NYSE
GOOY
Tidal ETF Trust
USOTC
MZHOF
Mizuho Finl (PK)
LSE
FM86
Atlas 2023-1 61
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés